Gallinamide A (TFA)
Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) (IC50: 17.6 pM) . Gallinamide A TFA inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM) . Gallinamide A TFA also inhibits Plasmodium falciparum (IC50: 50 nM) [1][2].
Product Specifications
CAS Number
1352920-57-0
UNSPSC
12352005
Target
Cathepsin; Parasite; SARS-CoV
Type
Natural Products
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/gallinamide-a-tfa.html
Purity
99.85
Solubility
10 mM in DMSO
Smiles
CC[C@H](C)[C@H](N(C)C)C(O[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](C)/C=C/C(N1[C@H](C(OC)=CC1=O)C)=O)=O)=O)=O.OC(C(F)(F)F)=O
Molecular Formula
C33H53F3N4O9
Molecular Weight
706.79
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
